Combination of irreversible electroporation with sustained release of a synthetic membranolytic polymer for enhanced cancer cell killing

Keyphrases

• Irreversible Electroporation 100%
• Sustained Release 100%
• Membranolytic Activity 100%
• Cancer Cell Killing 100%
• Methacrylate 50%
• Solid Tumors 25%
• Ablating 25%
• Sensitizer 25%
• Electric Field Strength 25%
• Combination Therapy 12%
• Monotherapy 12%
• Small Molecules 12%
• Cancer Cells 12%
• Surfactant 12%
• Therapeutic Potential 12%
• New Therapeutics 12%
• Cell Killing 12%
• Low Molecular Weight 12%
• Tumor Tissue 12%
• Lack of Control 12%
• Large Tumors 12%
• Focal Therapy 12%
• Enhanced Efficacy 12%
• Poor Stability 12%
• Low Electric Field 12%
• Physiological Media 12%
• Temporal Accumulation 12%
• Membrane Lysis 12%
• Synergize 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Sustained Release 100%
• Methacrylate 100%
• Malignant Neoplasm 100%
• Solid Malignant Neoplasm 50%
• Bioavailability 50%
• Neoplasm 50%
• Surfactant 25%
• Combination Therapy 25%
• Monotherapy 25%

Immunology and Microbiology

• Cell Killing 100%
• Cancer Cell 100%
• Sustained Drug Release 100%
• Electroporation 100%
• Sensitization 37%
• Electric Field 25%
• Molecular Weight 12%